03 March 2017
The Defence Materials Technology Centre (DMTC) is a not for profit collaborative venture that brings together defence industry, universities and government research agencies to develop technologies that will enhance Australia’s defence and national security capability.
The Medical Countermeasures (MCM) activity being hosted by DMTC is focused on vaccines, therapeutics and diagnostics for the protection of military and civilian personnel against Chemical Biological and Radiological (CBR) threats, emerging infectious diseases and pandemics.
Released on 3 March, this call for Expressions of Interest for collaborative projects focuses on three priority areas:
- Point of Care Diagnostics
- Antimicrobial Resistance and
- Security Sensitive Biological Agents
Proposed projects must have a minimum of one industry partner and one academic/research partner.
The program is about translation of technology and therefore all proposed projects must be at or above the non-clinical/preclinical phase of development for vaccines and therapeutics; and a prototype for diagnostics.
The following guidance is provided to assist with your application:
- DMTC MCM Program Information guide;
- DMTC MCM Technology Readiness Levels guide; and
- Template for DMTC MCM Quadchart submission.
Quad Charts must be submitted by no later than 1600hrs AEDT on Friday March 17, 2017. No late submissions will be accepted.
Visit the DMTC website for more information.